Obesity-associated inflammation in liver, pancreas and white adipose tissue (WAT), accompanied by insulin resistance and hepatic steatosis, was potentiated by pharmacological CB2 receptor activation and diminished in globally CB2-deficient mice. The gene discussed is CNR2; the disease is obesity disorder.